3SBio Discontinues NuLeusin; Sinovac To Benefit From Government Vaccine Supply Plan: China Earnings Roundup (Part 3)
This article was originally published in PharmAsia News
Executive Summary
China's generic pharma companies suffered a slowdown in Q3, but biotech companies saw healthy growth.